ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis.
Saved in:
| Title: | ASO Author Reflections: Does Adjuvant Therapy Confer a Survival Benefit in Patients Receiving Neoadjuvant Chemotherapy for Pancreatic Cancer? A CA19-9 Analysis. |
|---|---|
| Authors: | Liu H; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA., Zureikat A; Department of Surgery, University of Pittsburgh Medical Center, Pittsburgh, PA, 15213, USA. zureikatah@upmc.edu. |
| Source: | Annals of surgical oncology [Ann Surg Oncol] 2020 Oct; Vol. 27 (10), pp. 3961-3962. Date of Electronic Publication: 2020 May 05. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Springer Country of Publication: United States NLM ID: 9420840 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1534-4681 (Electronic) Linking ISSN: 10689265 NLM ISO Abbreviation: Ann Surg Oncol Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
